Clinical Trial Update: Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining changes in corneal thickness during riboflavin/UVA corneal collagen cross-linking in eyes with progressive keratoconus a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Riboflavin (Vitamin B2) solution (riboflavin)

Snippet

Sponsor: Instituto de Olhos de Goiania | Conditions: Progressive Keratoconus, Thin Corneas | Phase 4 | Status: COMPLETED